Literature DB >> 32073980

Re: Impact of 5α-Reductase Inhibitor and α-Blocker Therapy for Benign Prostatic Hyperplasia on Prostate Cancer Incidence and Mortality.

Steven A Kaplan.   

Abstract

Entities:  

Year:  2020        PMID： 32073980     DOI： 10.1097/JU.0000000000000763.02

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  1 in total

1.  Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia.

Authors:  Ramona D'Amico; Tiziana Genovese; Marika Cordaro; Rosalba Siracusa; Enrico Gugliandolo; Alessio Filippo Peritore; Livia Interdonato; Rosalia Crupi; Salvatore Cuzzocrea; Rosanna Di Paola; Roberta Fusco; Daniela Impellizzeri
Journal:  Antioxidants (Basel)       Date:  2021-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.